In the course of our screening for anti-peronosporomycetal agents, we isolated a new compound khatmiamycin (1), together with five known metabolites, GTRI-02 (3), 4-ethyl-5-methyl-heptanamide (4), aloesaponarin II (5), LL-C10037a (6) and LL-C10037b (7) from the culture broth of a terrestrial Streptomyces sp. ANK313. The structures of these metabolites were assigned on the basis of their spectroscopic data. Khatmiamycin (1) exhibited potent motility inhibitory (100%) and lytic (83±7%) activities against zoospores of the grapevine downy mildew pathogen Plasmopara viticola at 10 mg ml À1 , followed by compounds 5 (MIC 25 mg ml À1 ), 7, 6, 3 in the order of decreasing activity. Khatmiamycin (1) also showed potent antibacterial activity against Staphylococcus aureus and Streptomyces viridochromogenes (Tü 57) by causing inhibition zones of 11 and 14 mm diameter, respectively, at the dose of 40 lg per disk. This is the first report on motility inhibitory and lytic activities of metabolites from a terrestrial Streptomyces species against the zoospores of downy mildew pathogen P. viticola.
INTRODUCTION
Peronosporomycetes are distinct from fungi and are phylogenetic relatives of brown algae and diatoms. They cause many destructive diseases in plants, animals, fishes and humans. 1,2 One of the most notorious members of peronosporomycetes, Plasmopara viticola, is an obligate biotroph and a serious pathogen of grapevine worldwide. Many fungicides are ineffective against this phytopathogen, and hence, bioactive compounds with new modes of action are needed to combat this economically important pest. Under favorable environmental conditions, the fungus-like stramenopile, P. viticola infects grapevine leaves through characteristic biflagellate motile zoospores released from airborne sporangia coming from other infected plants. The zoospores aggregate to stomata of the grapevine leaf by swimming through water film and then rapidly encyst to become round cystospores by shedding their flagella. 3, 4 The cystospores then rapidly germinate to form germ tubes and penetrate host tissue through the stomata. Disruption of any of these asexual stages eliminates the potential for pathogenesis. 5 The success of any zoosporic pathogen can be attributed in part to the speed of asexual differentiation to generate bi-flagellated motile zoospores and their ability to find a host through chemotaxis. 6 Therefore, compounds that can interfere with normal swimming behavior and early development of P. viticola are supposed to be important as lead compounds in the management of this notorious phytopathogen. 4 Streptomycetes are known to produce diverse groups of interesting bioactive secondary metabolites. 7 In the course of screening for secondary metabolites from actinomycetes, we found that the crude extract of a terrestrial Streptomyces sp. ANK313 remarkably inhibited motility of P. viticola zoospores and caused subsequent lysis at 100 mg ml À1 . This observation prompted us to isolate and characterize the motility-inhibitory and lytic factors in the extracts by chromatographic fractionation. We have discovered a new motility inhibitor and zoosporicide named khatmiamycin (1) along with five known compounds from extracts of the culture broth of Streptomyces sp. ANK313. This study describes the isolation, structure elucidation and biological activity of khatmiamycin (1) and further known compounds towards zoospores of Plasmopara viticola.
MATERIALS AND METHODS
Optical rotation was measured on a Perkin-Elmer polarimeter (model 241) (Perkin-Elmer, San Jose, CA, USA). -NMR spectra were measured on a Varian Inova 600 (599.740 MHz) and a Varian Unity 300 (300.145 MHz) spectrometer.
-ESI mass spectra were recorded on a Quattro Triple Quadrupol mass spectrometer with a Finnigan TSQ 7000 with nano-ESI API ion source. -HRESI mass spectra were measured on a Micromass LCT mass spectrometer coupled with a HP 1100 HPLC and a diode array detector. Column chromatography was carried out on MN silica gel 60, 0.05-0.2 mm; TLC was performed on Polygram SIL G/UV 254 . All silica gel materials were purchased from Macherey-Nagel, Düren, Germany. -Size exclusion chromatography was done on Sephadex LH-20 (Lipophilic Sephadex; Amersham Biosciences, Freiburg, Germany, purchased from Sigma-Aldrich Chemie, Steinheim, Germany). XAD-16 adsorber resin was obtained from Rohm and Haas (Frankfurt, Germany).
Taxonomy of the producing strain
Streptomyces sp. ANK313 has been derived from a soil sample (Kaiserslautern) and was isolated on YMG agar at room temperature (YMG agar: 2 g l À1 yeast extract, 5 g l À1 malt extract, 5 g l À1 glucose, 15 g l À1 agar, 30 mg l À1 cycloheximide). Its 16 S rRNA gene sequence was deposited in GenBank with the Accession Nr. HQ662219. The sequence shows high similarities to Streptomyces ansochromogenes subsp. ansochromogenes strain NBRC 13665 with 99.7% (GenBank Accession Nr. AB184448), and to Streptomyces achromogenes subsp. streptozoticus strain NBRC 14001 (GenBank Accession Nr. AB184562), as well as to Streptomyces nogalater strain NBRC 13445 (GenBank Accession Nr. AB184408), both with 99.6% homology. The strain Streptomyces sp. ANK313 is deposited in the culture collection at the Institute of Organic and Biomolecular Chemistry, Göttingen, Germany.
Fermentation, extraction and isolation
The Streptomyces sp. ANK313 was cultivated on M 2 + medium for 7 days and extracted with ethyl acetate (mycelium) and XAD-16 resin (filtrate), respectively, as described for related strains. 8 The combined extracts were chromatographed on silica gel using a CH 2 Cl 2 /MeOH gradient (0-10% MeOH) to obtain three fractions ( Figure 1 ). On TLC, fraction II showed two yellow components, which were further purified on Sephadex LH-20 followed by PTLC and again Sephadex LH-20 to get three compounds 1 (2.6 mg), 3 (5.8 mg) and 4 (7.0 mg). Fraction III was subjected to Sephadex LH-20 using MeOH followed by RP-18 to deliver compounds 5 (2.1 mg) and 6 (19.5 mg). Purification of fraction IV on RP18 followed by PTLC revealed finally compound 7 (9.9 mg); for structures, see Figure 2 ).
Production of zoospores and bioassay
Sporangia of P. viticola were isolated from the infected leaves of grapevine (Vitis vinifera cv. Müller-Thurgau) stalk received from Prof Beate Berkelmann, Geisenheim Research Center, Germany. This strain was originally gained from infected leaf materials of the grapevine cv. Riesling in 1996 and since then always propagated on fresh leaves of Müller-Thurgau. The strain was maintained by regular culturing on the lower surface of young grapevine leaves on Petri dishes containing 1.5% agar at 25 1C and 95% relative humidity. 4 At day 6 of cultivation, the sporangiophores bearing lemon-shaped sporangia were harvested into an Eppendorf vial by a micro-vacuum cleaner. 4 The freshly harvested sporangia were separated from sporangiophores by filtration through a nylon sieve (50 mm mesh), washed twice with distilled water and then incubated in sterilized tap water (3Â10 4 sporangia per ml) in the dark for 6 h at room temperature (23 1C) to release zoospores. These zoospores remained motile for 10-12 h in sterilized water and were used for the bioassay. dimethyl sulfoxide (DMSO) and then diluted with distilled water. The concentration of DMSO in the zoospore suspension never exceeded 1% (v/v), a condition that does not affect zoospore motility. The bioassay was carried out as described earlier. 5, 9 Briefly, 40 ml of sample suspension was directly added to 360 ml of zoospore suspension (ca. 10 5 per ml) taken in a dish of plant tissue culture multi-well plate to make a final volume of 400 ml and then quickly mixed with a glass rod; 1% aqueous DMSO was used as a control. The motility of zoospores was observed under a light microscope at 10-fold magnification. Quantification of time-course changes of motility and lysis of zoospores were carried out as described earlier. 4 Each treatment was replicated thrice. The mean value (%)±s.e. (standard error) of the affected spores in each treatment was calculated.
RESULTS AND DISCUSSION
Compound 1 was isolated as yellow solid (Table 1) ; it showed UV absorption at 254 nm, turned to black with anisaldehyde/sulfuric acid and became blue with 2 N NaOH on TLC, indicating a peri-hydroxyquinone.
The 1 H NMR spectrum of 1 displayed an aromatic ABC system for three adjacent protons (see Supplementary Figure S1 ). In addition, there was a further narrow doublet at d 7.04 (J¼1.4 Hz). In the aliphatic region, the spectrum showed two oxygen-bound protons by signals at d 4.79 and 4.21, a methoxy signal at d 3.69 and diastereotopic methylene protons at d 2.78 and 2.66. In the 13 C NMR (see Supplementary Figure S2 ) and HSQC spectra, there were 15 carbon signals as indicated by the HR ESIMS-derived formula C 15 H 14 O 7 . Two ketone carbonyl groups at d 190.3 and 184.5, one carbonyl of an acid or ester at d 173.1, eight sp 2 carbons (four quaternary and four methine carbons) and four sp 3 carbons (two oxygenated CH, one OCH 3 and one CH 2 ) completed the spectrum (Table 2) .
The HMBC spectrum showed correlations from H-7 to C-5 and C-8a, the former one (C-5) could be linked to oxygen, from H-8 to C-1 (184.5, CO), C-6 and C-4a, from H-6 to C-8 and C-4a. Furthermore, H-3 showed couplings with C-1 (CO), C-2, C-4a and C-9 of fragment II. H-11 and the methoxy group showed correlations with the carbonyl of an ester at d 173.1 (C-12). According to the above spectroscopic data, a partial structure (Figure 3) with seven of the nine double-bond equivalents can be drawn.
The remaining ketone carbonyl at d 190.3 showed no correlations. Placing this carbonyl at C-4 and closing the ring for the remaining double-bond equivalent completes structure 1.
Numerous quinone derivatives have been isolated from Streptomyces spp. and fungi. Most heptaketides among them are having an additional annellated ring, forming anthraquinones or naphthopyranequinones, whereas compound 1 bears an open chain. Closely related with 1 are the juglomycins 10 A (2a) and B (2b) and the juglone derivative NHAB. 11 Five further metabolites were identified as GTRI-02 (3), 12 4-ethyl-5-methyl-heptanamide (4), 13 aloesaponarin II (5), 14 LL-C10037a (6), 15 and LL-C10037b (7) 16 by means of AntiBase and comparison of their data with the literature.
Motility inhibitory and lytic activities of khatmiamycin and other metabolites against P. viticola zoospores
The motility inhibitory and zoosporicidal activities of khatmiamycin (1) and the other metabolites of Streptomyces sp. ANK313 against downy mildew pathogen P. viticola are summarized in Table 3 and Figure 4 . The motility of P. viticola zoospores was remarkably inhibited by 1 and 3-7 at low doses. Among the tested compounds, the highest motility inhibitory and lytic activities were recorded for compound 1 (MIC, 10 mg ml À1 ) followed by compound 5 (MIC, 25 mg ml À1 ). Other three compounds (3, 6 and 7) showed almost equal strength of motility inhibitory and lytic activities against zoospores at 50 mg ml À1 .
Microscopic observation revealed that the crude extract and isolated metabolites showed zoosporicidal activity against P. viticola almost in a similar manner: initially, the zoospores were halted and the cellular materials gradually fragmented and dispersed into the surrounding water medium by bursting cell membranes. Motility inhibition and subsequent lysis of zoospores of the sugar beet damping-off pathogen Aphanomyces cochlioides by various kinds of natural products such as polyflavonoid tannins from the bark of Lannea coromandelica, 9 anacardic acids from Ginkgo biloba, 17 saponins from Panax notoginseng and macrocyclic lactam antibiotics from Lysobacter sp. SB-K88 5 have been published. This is the first report on motility inhibition and lysis of zoospores of the downy mildew pathogen P. viticola by secondary metabolites from a terrestrial Streptomyces species. Motility of zoospores has been found critical for disease cycle and also virulence of the peronosporomycete phytopathogens. 3,18 Our observation indicated that Streptomyces spp. produce potent new secondary metabolites, which might be useful for biorational and sustainable management of the peronosporomycete phytopathogens. Therefore, further studies on isolation of more zoospore regulating principles from other Streptomyces spp. may result in interesting metabolites or lead compounds with novel modes of action for developing effective control strategy against notorious peronosporomycete phytopathogens. Khatmiamycin (1) also showed potent antibacterial activity against Staphylococcus aureus and Streptomyces viridochromogenes (Tü57) by causing growth inhibition zones 11 and 14 mm, respectively at the dose of 40 mg per paper disk. Khatmiamycin (1) belongs to the group of juglone derivatives, which are known to be cytotoxic 19 or to show activity against methicillin-resistant staphylococcal strains. 20 In previous reports GTRI-02 (3) was found to be a lipid peroxidation inhibitor, 13 and LL-C10037a (6) exhibited antitumor activity. In our cytotoxicity tests using brine shrimps, 1 was, however, with 10% mortality at 10 mg ml À1 nearly inactive.
CONCLUSION
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